Hardingham, J E <br/><br/>
Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 1995 
 - 1073-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1995.13.5.1073  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blotting, Southern<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Genetic Markers<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Non-Hodgkin--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Recurrence<br/>Regression Analysis<br/>Survival Analysis<br/>Translocation, Genetic--genetics<br/>Treatment Outcome